Hui Liang
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Cancer Research top 10%
- Oncology top 10%
- Surgery
- Co-authors
- Zhu WangJianwen ZhangQiong DengYing ZhangShengping ZhangY. Z. WanFang HeZhenwei Peng
- Topics
- Cancer-related molecular mechanisms research (12 papers)MicroRNA in disease regulation (11 papers)Kidney Stones and Urolithiasis Treatments (10 papers)
- Journals
- Journal of Clinical OncologySHILAP Revista de lepidopterologíaPLoS ONE
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Hui Liang
140 papers receiving 1.9k citations
Hit Papers
Peers
Comparison fields: 5 of 148
- Molecular Biology 726
- Pulmonary and Respiratory Medicine 429
- Cancer Research 301
- Oncology 294
- Surgery 209
Countries citing papers authored by Hui Liang
This map shows the geographic impact of Hui Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui Liang more than expected).
Fields of papers citing papers by Hui Liang
This network shows the impact of papers produced by Hui Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui Liang. The network helps show where Hui Liang may publish in the future.
Co-authorship network of co-authors of Hui Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Hui Liang. A scholar is included among the top collaborators of Hui Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui Liang. Hui Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 3 | |
| 5 | 3 | |
| 6 | 9 | |
| 7 | 1 | |
| 8 | 9 | |
| 9 | 10 | |
| 10 | 1 | |
| 11 | 13 | |
| 12 | 7 | |
| 13 | 12 | |
| 14 | MET Oncogene in Non-Small Cell Lung Cancer: Mechanism of MET Dysregulation and Agents Targeting the HGF/c-Met Axis | 5 |
| 15 | 8 | |
| 16 | 4 | |
| 17 | 17 | |
| 18 | 59 | |
| 19 | EFFECT OF APLYSIN ON PROLIFERATION AND VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION IN HUMAN BREAST CANCER CELL LINE | 2 |
| 20 | 2 |
About Hui Liang
Hui Liang is a scholar working on Cancer Research, Hepatology and Molecular Biology, having authored 152 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (11 papers) and Kidney Stones and Urolithiasis Treatments (10 papers). The work is most often cited by research in Molecular Medicine (194 citations), Cancer Research (301 citations) and Endocrinology (94 citations). Hui Liang has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Zhu Wang, Jianwen Zhang, Qiong Deng, Ying Zhang, Qiong Deng, Shengping Zhang, Y. Z. Wan, Fang He, Zhenwei Peng and Sudha R. Raman. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.